14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      RISK OF CARDIOVASCULAR DISEASE MORBIDITY AND MORTALITY IN FRAIL AND PRE-FRAIL OLDER ADULTS: RESULTS FROM A META-ANALYSIS AND EXPLORATORY META-REGRESSION ANALYSIS

      research-article
      , MD 1 , 2 , , MD, PhD 3 , , PhD 4 , 5 , , MD 2 , 6 , 7 , , MD 8 , 9 , , MD 1 , 10 , , MD 1 , , MD 11 , , MD 12 , , MD 13 , 14 , 15 , , MD 16 , 17 , , MD 18 , 19 , , MD 20 , , MD 21 , , MD 22 , , MD 23 , , MD 23 , , MD 24 , , MD 24 , , MD 24 , , MD 25 , , MD 26 , , MD 26 , , MD 27 , , MD 28 , , MD 10 , , MD 29 , 30 , 31 , 32
      Ageing research reviews
      frailty, cardiovascular disease, meta-analysis

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Frailty is common and associated with poorer outcomes in the elderly, but its role as potential cardiovascular disease (CVD) risk factor requires clarification. We thus aimed to meta-analytically evaluate the evidence of frailty and pre-frailty as risk factors for CVD. Two reviewers selected all studies comparing data about CVD prevalence or incidence rates between frail/pre-frail vs. robust. The association between frailty status and CVD in cross-sectional studies was explored by calculating and pooling crude and adjusted odds ratios (ORs) ±95% confidence intervals (CIs); the data from longitudinal studies were pooled using the adjusted hazard ratios (HRs). Eighteen cohorts with a total of 31,343 participants were meta-analyzed. Using estimates from 10 cross-sectional cohorts, both frailty and pre-frailty were associated with higher odds of CVD than robust participants. Longitudinal data were obtained from 6 prospective cohort studies. After a median follow-up of 4.4 years, we identified an increased risk for faster onset of any-type CVD in the frail (HR=1.70 [95%CI, 1.18–2.45]; I 2=66%) and pre-frail (HR=1.23 [95%CI, 1.07–1.36]; I 2=67%) vs. robust groups. Similar results were apparent for time to CVD mortality in the frail and pre-frail groups. In conclusion, frailty and pre-frailty constitute addressable and independent risk factors for CVD in older adults.

          Related collections

          Author and article information

          Journal
          101128963
          29630
          Ageing Res Rev
          Ageing Res. Rev.
          Ageing research reviews
          1568-1637
          1872-9649
          7 June 2018
          28 January 2017
          May 2017
          16 July 2018
          : 35
          : 63-73
          Affiliations
          [1 ]Department of Medicine (DIMED), Geriatrics Division, University of Padova, Italy
          [2 ]Institute of clinical Research and Education in Medicine (IREM), Padova, Italy
          [3 ]Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
          [4 ]Physiotherapy Department, South London and Maudsley NHS FoundationTrust, Denmark Hill, London SE5 8AZ, United Kingdom
          [5 ]Health Service and Population Research Department, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8 AF, United Kingdom
          [6 ]Department of Neurosciences, University of Padova, Padova, Italy
          [7 ]National Health Care System, Monselice, Padova Local Unit ULSS 17, Italy
          [8 ]Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy
          [9 ]Surgical Pathology Unit, Santa Chiara Hospital, Trento, Italy
          [10 ]National Research Council, Neuroscience Institute - Aging Branch, Padova, Italy
          [11 ]South Oaks Hospital, Northwell Health, 400 Sunsrise Highway, Amityville, NY 11701, USA, USA
          [12 ]Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
          [13 ]Division of Geriatrics and Nutritional Sciences and Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO, USA
          [14 ]Department of Clinical and Experimental Sciences, Brescia University, Brescia, Italy
          [15 ]CEINGE Biotecnologie Avanzate, Napoli, Italy
          [16 ]University of Helsinki and Helsinki University Hospital, Helsinki, Finland
          [17 ]University of Oulu, Center for Life Course Health Research, Oulu, Finland
          [18 ]Centre de Recherche Inserm, Bordeaux, France
          [19 ]University Victor Segalen Bordeaux 2, Bordeaux, France
          [20 ]CMRR Paris Nord AP-HP, Groupe Hospitalier Lariboisière Fernand-Widal Saint-Louis, INSERM, U942, Université Paris Diderot, Sorbonne Paris Cité, UMRS 942, Paris, France
          [21 ]CESP, Univ. Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France
          [22 ]University of Bordeaux, Neuroepidemiology, UMR897, Bordeaux, France
          [23 ]University of Zurich, Epidemiology, Biostatistics and Prevention Institute, Division of Chronic Disease Epidemiology, Hirschengraben 84, CH-8001 Zurich, Switzerland
          [24 ]Division of Cardiology, Department of Science, Città della Salute e della Scienza, Turin, Italy
          [25 ]Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
          [26 ]Department of Internal Medicine, Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, Brazil
          [27 ]Department of Cardiology, Hospital Clínico Universitario, School of Medicine, University of Valencia, Valencia, Spain
          [28 ]Clinical Epidemiology and Biometric Unit, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
          [29 ]The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA
          [32 ]Hofstra Northwell School of Medicine, Hempstead, NY, USA
          [33 ]The Feinstein Institute for Medical Research, Manhasset, NY, USA
          [32 ]Albert Einstein College of Medicine, Bronx, NY, USA
          Author notes
          Corresponding Author: Nicola Veronese, MD. University of Padova, Department of Medicine, Geriatrics Division, Padova, Italy. ilmannato@ 123456gmail.com . Phone: 00390498218492; fax: 00390498211218
          [*]

          These two authors equally contributed to this research.

          Article
          PMC6047747 PMC6047747 6047747 nihpa950132
          10.1016/j.arr.2017.01.003
          6047747
          28143778
          6735b3a0-35d8-4e81-969b-85e77e9809af
          History
          Categories
          Article

          meta-analysis,cardiovascular disease,frailty
          meta-analysis, cardiovascular disease, frailty

          Comments

          Comment on this article